Biotage AB OTC Stock Top Insiders
| BITGF Stock | USD 16.87 0.00 0.00% |
Biotage AB employs about 510 people. The company is managed by 29 executives with a total tenure of roughly 132 years, averaging almost 4.0 years of service per executive, having 17.59 employees per reported executive. Examination of Biotage AB's management performance can provide insight into the company performance.
| Torben Joergensen CEO President and CEO |
| Ove Mattsson Chairman Chairman of the Board of Directors |
Biotage |
Biotage AB Management Team Effectiveness
The company has return on total asset (ROA) of 0.109 % which means that it generated a profit of $0.109 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1785 %, meaning that it generated $0.1785 on every $100 dollars invested by stockholders. Biotage AB's management efficiency ratios could be used to measure how well Biotage AB manages its routine affairs as well as how well it operates its assets and liabilities.The company has Profit Margin (PM) of 0.16 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average.
Biotage AB Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Biotage AB Price Series Summation is a cross summation of Biotage AB price series and its benchmark/peer.
Biotage AB Notable Stakeholders
A Biotage AB stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Biotage AB often face trade-offs trying to please all of them. Biotage AB's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Biotage AB's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Torben Joergensen | President and CEO | Profile | |
| Ove Mattsson | Chairman of the Board of Directors | Profile | |
| Rikke Rytter | Vice President Global Marketing | Profile | |
| Anders Wikstrom | Vice President - Operations | Profile | |
| Lars Backman | Vice President of Corporate Development | Profile | |
| Paul Belton | Vice President - Business Development | Profile | |
| Erika Johnson | CFO | Profile | |
| Karolina Lawitz | Member of the Board of Directors | Profile | |
| NilsOlof Bjork | Director | Profile | |
| Love Amcoff | Director, Employee Representative | Profile | |
| Thomas Eklund | Member of the Board of Directors | Profile | |
| Mark Bradley | Director | Profile | |
| Cecilia Hallner | Global Human Resources Director | Profile | |
| Malin Albertsson | Director, Employee Representative | Profile | |
| Yvonne Martensson | Director | Profile | |
| Anders Walldov | Member of the Board of Directors | Profile | |
| Peter Ehrenheim | Member of the Board of Directors | Profile | |
| Annika Gardlund | Director, Employee Representative | Profile | |
| Petra Duprez | Chief Officer | Profile | |
| Jonas Stahlberg | Chief Auditor | Profile | |
| Raffaella Bombarda | EVP Marketing | Profile | |
| Steve Jordan | Chief Scientific Officer | Profile | |
| Scott Carr | Pres Americas | Profile | |
| Tomas Blomquist | CEO Pres | Profile | |
| Maja Nilsson | Chief Officer | Profile | |
| CS BSc | Ex Operations | Profile | |
| JonSverre Schanche | Chief Officer | Profile | |
| Olof Nord | Exec Devel | Profile | |
| Lars LLB | Chief Officer | Profile |
About Biotage AB Management Performance
The success or failure of an entity such as Biotage AB often depends on how effective the management is. Biotage AB management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Biotage management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Biotage management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Biotage AB provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. Biotage AB was founded in 1969 and is headquartered in Uppsala, Sweden. Biotage Ab is traded on OTC Exchange in the United States.
The data published in Biotage AB's official financial statements usually reflect Biotage AB's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Biotage AB. For example, before you start analyzing numbers published by Biotage accountants, it's critical to develop an understanding of what Biotage AB's liquidity, profitability, and earnings quality are in the context of the Biotage space in which it operates.
Please note, the presentation of Biotage AB's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biotage AB's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Biotage AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Biotage AB. Please utilize our Beneish M Score to check the likelihood of Biotage AB's management manipulating its earnings.
Biotage AB Workforce Analysis
Traditionally, organizations such as Biotage AB use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Biotage AB within its industry.Biotage AB Manpower Efficiency
Return on Biotage AB Manpower
| Revenue Per Employee | 2.4M | |
| Revenue Per Executive | 42.5M | |
| Net Income Per Employee | 402K | |
| Net Income Per Executive | 7.1M | |
| Working Capital Per Employee | 415.7K | |
| Working Capital Per Executive | 7.3M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotage AB. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Biotage AB information on this page should be used as a complementary analysis to other Biotage AB's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Biotage OTC Stock analysis
When running Biotage AB's price analysis, check to measure Biotage AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotage AB is operating at the current time. Most of Biotage AB's value examination focuses on studying past and present price action to predict the probability of Biotage AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotage AB's price. Additionally, you may evaluate how the addition of Biotage AB to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |